162 related articles for article (PubMed ID: 4790577)
1. Treatment of herpes simplex virus types 1 and 2 encephalitis in mice with 9-beta-D-arabinofuranosyladenine.
Sloan BJ; Miller FA; McLean IW
Antimicrob Agents Chemother; 1973 Jan; 3(1):74-80. PubMed ID: 4790577
[TBL] [Abstract][Full Text] [Related]
2. Target-organ treatment of neurotropic virus diseases: efficacy as a chemotherapy tool and comparison of activity of adenine arabinoside, cytosine arabinoside, idoxuridine, and trifluorothymidine.
Allen LB; Sidwell RW
Antimicrob Agents Chemother; 1972 Sep; 2(3):229-33. PubMed ID: 4790562
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of four antiviral agents in the treatment of herpes simplex encephalitis in a rat model.
Marks MI
J Infect Dis; 1975 Jan; 131(1):11-6. PubMed ID: 162922
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds.
Klein RJ; Friedman-Kien AE; Brady E
Antimicrob Agents Chemother; 1974 Mar; 5(3):318-22. PubMed ID: 4840439
[TBL] [Abstract][Full Text] [Related]
5. Herpes simplex virus encephalitis: therapy trials.
Lerner AM; Lauter CB; Nolan DC
Ann Intern Med; 1973 Aug; 79(2):285. PubMed ID: 4726549
[No Abstract] [Full Text] [Related]
6. Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice.
de Clercq E; Zhang ZX; Sim IS
Antimicrob Agents Chemother; 1982 Sep; 22(3):421-5. PubMed ID: 7137983
[TBL] [Abstract][Full Text] [Related]
7. Therapy of experimental herpes simplex encephalitis with aciclovir in mice.
Park NH; Pavan-Langston D; McLean SL; Albert DM
Antimicrob Agents Chemother; 1979 Jun; 15(6):775-9. PubMed ID: 475362
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of 9-beta-D-arabinofuranosyladenine. VI. Effect of delayed treatment on herpes simplex virus in mice.
Miller FA; Sloan BJ; Silverman CA
Antimicrob Agents Chemother (Bethesda); 1969; 9():192-5. PubMed ID: 5396486
[No Abstract] [Full Text] [Related]
9. Effect of treatment with 1-beta-D-arabinofuranosylthymine of experimental encephalitis induced by herpes simplex virus in mice.
Machida H; Ichikawa M; Kuninaka A; Saneyoshi M; Yoshino H
Antimicrob Agents Chemother; 1980 Feb; 17(2):109-14. PubMed ID: 7387135
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in mice.
Shannon WM; Westbrook L; Arnett G; Daluge S; Lee H; Vince R
Antimicrob Agents Chemother; 1983 Oct; 24(4):538-43. PubMed ID: 6651280
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the in vitro and in vivo anti-herpes activities of 1-beta-D-arabinofuranosylthymine and its 5'-monophosphate.
Machida H; Sakata S; Morozumi M; Kiyanagi T; Kuninaka A; Yoshino H
Antiviral Res; 1982 Sep; 2(4):217-26. PubMed ID: 6293376
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the antiviral activity of acyl derivatives of 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine and other nucleosides against encephalitis in mice.
Nishiyama S; Sato K; Yamanaka T; Moffatt JG
Antimicrob Agents Chemother; 1977 Feb; 11(2):198-201. PubMed ID: 192142
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus.
Schinazi RF; Peters J; Sokol MK; Nahmias AJ
Antimicrob Agents Chemother; 1983 Jul; 24(1):95-103. PubMed ID: 6625559
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-deoxyribonucleic acid virus activity of certain 9-beta-D-arabinofuranosyl-2-substituted adenine derivatives.
Miyai K; Allen LB; Huffman JH; Sidwell RW; Tolman RL
J Med Chem; 1974 Feb; 17(2):242-4. PubMed ID: 4358433
[No Abstract] [Full Text] [Related]
15. Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.
Schinazi RF; Fox JJ; Watanabe KA; Nahmias AJ
Antimicrob Agents Chemother; 1986 Jan; 29(1):77-84. PubMed ID: 3015003
[TBL] [Abstract][Full Text] [Related]
16. Herpes encephalitis: controlled studies.
Hirsch MS; Levin M; Chien LT
Ann Intern Med; 1973 May; 78(5):779. PubMed ID: 4711782
[No Abstract] [Full Text] [Related]
17. Effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate on genital lesions and encephalitis induced by Herpesvirus hominis type 2 in female mice.
Allen LB; Hintz OJ; Wolf SM; Huffman JH; Simon LN; Robins RK; Sidwell RW
J Infect Dis; 1976 Jun; 133 Suppl():A178-83. PubMed ID: 6598
[TBL] [Abstract][Full Text] [Related]
18. Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenine.
Shannon WM; Westbrook L; Higuchi WI; Sugibayashi K; Baker DC; Kumar SD; Fox JL; Flynn GL; Ho NF; Vaidyanathan R
J Pharm Sci; 1985 Nov; 74(11):1157-61. PubMed ID: 4087174
[TBL] [Abstract][Full Text] [Related]
19. Nucleic acids. 14. Synthesis and antiviral activity of some 5'-esters of 9-beta-D-arabinofuranosyladenine (ara-A).
Renis HE; Gish DT; Court BA; Eidson EE; Wechter WJ
J Med Chem; 1973 Jul; 16(7):754-7. PubMed ID: 4353601
[No Abstract] [Full Text] [Related]
20. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
Ayisi NK; Gupta SV; Babiuk LA
Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
